The abstract is read at the publisher; the summary is JClub's.
In post-mortem schizophrenia case SZ07 with an exceptionally low schizophrenia polygenic risk score (below the first percentile), only an IZUMO4 splice-acceptor variant had direct RNA-level support.
- Why it matters: The work addresses how rare, larger-effect variants might be detected in individuals with very low common-variant burden, and how to connect genomic candidates to molecular effects in brain tissue.
- What they did: The study performed exome analysis using multiple variant-prediction tools to prioritize variants, then used RNA sequencing from three cortical regions to test RNA-level support.
- The result: Broader transcriptomic pathway analysis implicated innate immune processes, calcium signalling, synaptic biology, and axon remodelling, with results largely compatible with SZ07’s cerebrovascular disease history.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.